These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29445282)

  • 1. Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness.
    Omori Y; Kanbayashi T; Imanishi A; Tsutsui K; Sagawa Y; Kikuchi YS; Takeshima M; Yoshizawa K; Uemura S; Shimizu T
    Neuropsychiatr Dis Treat; 2018; 14():451-457. PubMed ID: 29445282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.
    Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1.
    Urata Y; Nakamura M; Shiokawa N; Yasuniwa A; Takamori N; Imamura K; Hayashi T; Ishizuka T; Kasugai M; Sano A
    Front Neurol; 2020; 11():12. PubMed ID: 32117000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypocretin neurotransmission system in myotonic dystrophy type 1.
    Ciafaloni E; Mignot E; Sansone V; Hilbert JE; Lin L; Lin X; Liu LC; Pigeon WR; Perlis ML; Thornton CA
    Neurology; 2008 Jan; 70(3):226-30. PubMed ID: 18195268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
    Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
    J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
    Dauvilliers YA; Laberge L
    Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wanted: a better cut-off value for the Epworth Sleepiness Scale.
    Trimmel K; Żebrowska M; Böck M; Stefanic A; Mayer D; Klösch G; Auff E; Seidel S
    Wien Klin Wochenschr; 2018 May; 130(9-10):349-355. PubMed ID: 29340766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin.
    Bassetti CL; Baumann CR; Dauvilliers Y; Croyal M; Robert P; Schwartz JC
    J Sleep Res; 2010 Dec; 19(4):620-3. PubMed ID: 20846244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.
    Sansone VA; Proserpio P; Mauro L; Biostat AL; Frezza E; Lanza A; Rogliani P; Pezzuto G; Falcier E; Aggradi CF; Pirola A; Rao F; Roma E; Galluzzi C; Spanetta M; Cattaneo F; Rubino A; Agostoni EC; Amico F; Zanolini A; Izzi F; Greco G; Romigi A; Liguori C; Nobili L; Placidi F; Massa R
    J Clin Sleep Med; 2021 Dec; 17(12):2383-2391. PubMed ID: 34170223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective and objective hypersomnia highly prevalent in adults with epilepsy.
    Grigg-Damberger M; Andrews N; Wang L; Bena J; Foldvary-Schaefer N
    Epilepsy Behav; 2020 May; 106():107023. PubMed ID: 32213453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepiness].
    Iwata T; Suzuki N; Mizuno H; Nakashima I; Kanbayashi T; Itoyama Y
    Rinsho Shinkeigaku; 2009 Jul; 49(7):437-9. PubMed ID: 19715174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.
    Yu H; Laberge L; Jaussent I; Bayard S; Scholtz S; Raoul M; Pages M; Dauvilliers Y
    Sleep; 2011 Feb; 34(2):165-70. PubMed ID: 21286250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R; Benninger D; Waldvogel D; Bassetti CL
    Eur Neurol; 2010; 63(3):129-35. PubMed ID: 20090346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Epworth Sleepiness Scale with multiple sleep latency test and its diagnostic accuracy in assessing excessive daytime sleepiness in patients with obstructive sleep apnea hypopnea syndrome.
    Cai SJ; Chen R; Zhang YL; Xiong KP; Lian YX; Li J; Shen JC; Liu CF
    Chin Med J (Engl); 2013; 126(17):3245-50. PubMed ID: 24033944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.